Genesis Healthcare, Inc.
US ˙ OTCPK ˙ US37185X1063

Introduction

This page provides a comprehensive analysis of the known insider trading history of Paul David Bach. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Paul David Bach has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:GENNQ / Genesis Healthcare, Inc. COO 952,089
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Paul David Bach. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases GENNQ / Genesis Healthcare, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in GENNQ / Genesis Healthcare, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GENNQ / Genesis Healthcare, Inc. Insider Trades
Insider Sales GENNQ / Genesis Healthcare, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in GENNQ / Genesis Healthcare, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2020-06-03 GEN Bach Paul David 7,457 0.9550 7,457 0.9550 7,121 730
2020-05-20 GEN Bach Paul David 20,781 0.6200 20,781 0.6200 12,884
2019-06-12 GEN Bach Paul David 12,418 1.1682 12,418 1.1682 14,507
2019-06-03 GEN Bach Paul David 8,616 1.1593 8,616 1.1593 9,989
2019-05-20 GEN Bach Paul David 11,540 1.1999 11,540 1.1999 13,847
2018-06-12 GEN Bach Paul David 5,735 2.2812 5,735 2.2812 13,083
2018-06-05 GEN Bach Paul David 10,131 2.1913 10,131 2.1913 22,200
2017-06-14 GEN Bach Paul David 6,100 1.7296 6,100 1.7296 10,551
2017-06-07 GEN Bach Paul David 2,769 1.6142 2,769 1.6142 4,470

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

GENNQ / Genesis Healthcare, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Paul David Bach as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-05-28 2021-05-15 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
F - Taxes -66,598 952,089 -6.54 0.24 -15,984 228,501
2020-06-04 2020-06-03 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
S - Sale -7,457 832,158 -0.89 0.96 -7,121 794,711
2020-06-04 2020-06-02 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 205,000 839,615 32.30
2020-05-22 2020-05-20 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
S - Sale -20,781 708,990 -2.85 0.62 -12,884 439,574
2019-06-14 2019-06-12 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
S - Sale -12,418 729,771 -1.67 1.17 -14,507 852,518
2019-06-05 2019-06-03 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
S - Sale -8,616 777,539 -1.10 1.16 -9,989 901,401
2019-05-22 2019-05-20 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
S - Sale -11,540 786,155 -1.45 1.20 -13,847 943,307
2019-05-16 2019-05-14 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 204,500 797,695 34.47
2019-02-12 2019-02-11 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
J - Other -5,388 593,195 -0.90
2019-01-03 2018-12-31 4 GEN Genesis Healthcare, Inc.
Class C Common Stock
J - Other -32 32 -50.00
2019-01-03 2018-12-31 4 GEN Genesis Healthcare, Inc.
Class A Common Units of FC-GEN Operations Investment, LLC
J - Other -186,499 186,497 -50.00
2018-12-26 2018-12-20 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
J - Other -152,722 598,583 -20.33
2018-06-13 2018-06-12 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
S - Sale -5,735 751,305 -0.76 2.28 -13,083 1,713,877
2018-06-07 2018-06-06 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 185,900 757,040 32.55
2018-06-07 2018-06-05 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
S - Sale -10,131 571,140 -1.74 2.19 -22,200 1,251,539
2017-06-15 2017-06-14 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
S - Sale -6,100 603,271 -1.00 1.73 -10,551 1,043,418
2017-06-09 2017-06-07 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
S - Sale -2,769 518,947 -0.53 1.61 -4,470 837,684
2017-06-01 2017-05-30 4 GEN Genesis Healthcare, Inc.
Class A Common Stock
A - Award 148,750 521,716 39.88
2017-01-09 3 GEN Genesis Healthcare, Inc.
Class A Common Stock
926,780
2017-01-09 3 GEN Genesis Healthcare, Inc.
Class A Common Stock
926,780
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)